ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration

Journal of the American College of Cardiology

Volumn 61, Issue 7, 2013, Pages 752-761

  Mahjoub, Haïfa ^a   Mathieu, Patrick ^a   Sénéchal, Mario ^a   Larose, Eric ^a   Dumesnil, Jean ^a   Després, Jean Pierre ^a   Pibarot, Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

ApoB ApoA I ratio; Doppler echocardiography; heart valve prosthesis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BISPHOSPHONIC ACID DERIVATIVE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE DYSFUNCTION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; STRUCTURAL VALVE DEGENERATION; VALVULAR HEART DISEASE;

AGED; AORTIC VALVE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BIOPROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; RISK FACTORS;

EID: 84873634842     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.033     Document Type: Article

References (44)

1. F.J. Schoen, R.J. Levy Calcification of tissue heart valve substitutes: progress toward understanding and prevention Ann Thorac Surg 79 2005 1072 1080
2. J.M. Vesey, C.M. Otto Complications of prosthetic heart valves Curr Cardiol Rep 6 2004 106 111
3. D. Skowasch, M. Steinmetz, G. Nickenig, G. Bauriedel Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology Expert Rev Med Devices 3 2006 453 462
4. M. Ruel, A. Kulik, F.D. Rubens Late incidence and determinants of reoperation in patients with prosthetic heart valves Eur J Cardiothorac Surg 25 2004 364 370
5. T. Bottio, G. Thiene, E. Pettenazzo Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants J Thorac Cardiovasc Surg 126 2003 99 105
6. R. Shetty, P. Pibarot, A. Audet Lipid-mediated inflammation and degeneration of bioprosthetic heart valves Eur J Clin Invest 39 2009 471 480
7. E.R. Mohler, M.J. Sheridan, R. Nichols, W.P. Harvey, B.F. Waller Development and progression of aortic valve stenosis: atherosclerosis risk factors-a causal relationship? A clinical morphologic study Clin Cardiol 14 1991 995 999
8. C.M. Otto, J. Kuusisto, D.D. Reichenbach, A.M. Gown, K.D. O'Brien Characterization of the early lesion of "degenerative" valvular aortic stenosis Histological and immunohistochemical studies Circulation 90 1994 844 853
9. R.V. Freeman, C.M. Otto Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies Circulation 111 2005 3316 3326
10. C. Cote, P. Pibarot, J.P. Despres Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis Heart 94 2008 1175 1180
11. R.S. Farivar, L.H. Cohn Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation J Thorac Cardiovasc Surg 126 2003 969 975
12. M. Briand, P. Pibarot, J.P. Despres Metabolic syndrome is associated with faster degeneration of bioprosthetic valves Circulation 114 2006 I512 I517
13. G. Nollert, J. Miksch, E. Kreuzer, B. Reichart Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement J Thorac Cardiovasc Surg 126 2003 965 968
14. W.A. Zoghbi, J.B. Chambers, J.G. Dumesnil Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography J Am Soc Echocardiogr 22 2009 975 1014 quiz 1082-4
15. Executive summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
16. G.R. Warnick, R.H. Knopp, V. Fitzpatrick, L. Branson Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints Clin Chem 36 1990 15 19
17. B. Lamarche, A. Tchernof, P. Mauriege Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease JAMA 279 1998 1955 1961
18. A.C. St-Pierre, I.L. Ruel, B. Cantin Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease Circulation 104 2001 2295 2299
19. T.Q. Callister, B. Cooil, S.P. Raya, N.J. Lippolis, D.J. Russo, P. Raggi Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method Radiology 208 1998 807 814
20. M. Ferland, J.P. Despres, A. Tremblay Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements Br J Nutr 61 1989 139 148
21. R.O. Bonow, B.A. Carabello, K. Chatterjee 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e1 e240
22. P. Pibarot, J.G. Dumesnil Prosthetic heart valves: selection of the optimal prosthesis and long-term management Circulation 119 2009 1034 1048
23. W. Flameng, M.C. Herregods, M. Vercalsteren, P. Herijgers, K. Bogaerts, B. Meuris Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves Circulation 121 2010 2123 2129
24. F. Antonini-Canterin, A. Zuppiroli, B.A. Popescu Effect of statins on the progression of bioprosthetic aortic valve degeneration Am J Cardiol 92 2003 1479 1482
25. R. Lorusso, S. Gelsomino, F. Luca Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study Circulation 125 2012 604 614
26. G. Walldius, I. Jungner Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy J Intern Med 255 2004 188 205
27. S. Yusuf, S. Hawken, S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
28. C. Meisinger, H. Loewel, W. Mraz, W. Koenig Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study Eur Heart J 26 2005 271 278
29. A.C. St-Pierre, B. Cantin, G.R. Dagenais, J.P. Despres, B. Lamarche Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men Am J Cardiol 97 2006 997 1001
30. B.J. Arsenault, J.P. Despres, E.S. Stroes Lipid assessment, metabolic syndrome and coronary heart disease risk Eur J Clin Invest 40 2010 1081 1093
31. G. Walldius, I. Jungner, A.H. Aastveit, I. Holme, C.D. Furberg, A.D. Sniderman The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk Clin Chem Lab Med 42 2004 1355 1363
32. E. Di Angelantonio, P. Gao, L. Pennells Lipid-related markers and cardiovascular disease prediction JAMA 307 2012 2499 2506
33. A.H. Skolnick, M. Osranek, P. Formica, I. Kronzon Osteoporosis treatment and progression of aortic stenosis Am J Cardiol 104 2009 122 124
34. S. Elmariah, J.A. Delaney, K.D. O'Brien Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (the Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 56 2010 1752 1759
35. D.L. Tribble, L.G. Holl, P.D. Wood, R.M. Krauss Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size Atherosclerosis 93 1992 189 199
36. D. Mohty, P. Pibarot, J.P. Despres Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis Arterioscler Thromb Vasc Biol 28 2008 187 193
37. R. Shetty, N. Girerd, N. Cote Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses Cardiology 121 2012 20 26
38. A.L. Borel, J.A. Nazare, J. Smith Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program Obesity (Silver Spring) 20 2012 1223 1233
39. S.E. Nissen, S.J. Nicholls, I. Sipahi Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
40. J.R. Downs, M. Clearfield, S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
41. S.J. Cowell, D.E. Newby, R.J. Prescott A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397
42. A.B. Rossebo, T.R. Pedersen, K. Boman Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
43. K.L. Chan, K. Teo, J.G. Dumesnil, A. Ni, J. Tam Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314
44. A. Kulik, R.G. Masters, P. Bedard Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial? Eur J Cardiothorac Surg 37 2010 139 144